GRIFULVIN V Drug Patent Profile
✉ Email this page to a colleague
When do Grifulvin V patents expire, and what generic alternatives are available?
Grifulvin V is a drug marketed by Johnson And Johnson, Valeant Luxembourg, and J And J. and is included in four NDAs.
The generic ingredient in GRIFULVIN V is griseofulvin, microsize. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the griseofulvin, microsize profile page.
Summary for GRIFULVIN V
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Clinical Trials: | 2 |
Patent Applications: | 109 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GRIFULVIN V at DailyMed |
Recent Clinical Trials for GRIFULVIN V
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Actavis Inc. | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for GRIFULVIN V
US Patents and Regulatory Information for GRIFULVIN V
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Johnson And Johnson | GRIFULVIN V | griseofulvin, microcrystalline | SUSPENSION;ORAL | 050448-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Luxembourg | GRIFULVIN V | griseofulvin, microcrystalline | TABLET;ORAL | 062279-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
J And J | GRIFULVIN V | griseofulvin, microcrystalline | TABLET;ORAL | 060618-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Luxembourg | GRIFULVIN V | griseofulvin, microsize | TABLET;ORAL | 062279-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |